Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Profound Medical Q2 EPS $(0.52) Misses $(0.35) Estimate, Sales $2.211M Miss $3.533M Estimate

Author: Benzinga Newsdesk | August 14, 2025 03:09pm
Profound Medical (NASDAQ:PROF) reported quarterly losses of $(0.52) per share which missed the analyst consensus estimate of $(0.35) by 47.73 percent. This is a 85.71 percent decrease over losses of $(0.28) per share from the same period last year. The company reported quarterly sales of $2.211 million which missed the analyst consensus estimate of $3.533 million by 37.41 percent. This is a 0.99 percent decrease over sales of $2.233 million the same period last year.

Posted In: PROF


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist